Adequan i.m (polysulfated glycosaminoglycan) is the only FDA-approved PSGAG for degenerative joint disease (DJD) in horses. Adequan i.m. treats the disease, not just its clinical signs by reducing inflammation, restoring synovial joint lubrication, repairing joint cartilage and reversing the disease process. For over 30 years, Adequan i.m has been prescribed by veterinarians to help horses of every discipline and level enjoy greater mobility over their lifetimes. There is no generic version of Adequan i.m.
Adequan i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.